Global Carbohydrate Antigen 19-9 Market Growth 2023-2029

Global Carbohydrate Antigen 19-9 Market Growth 2023-2029

Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
LPI (LP Information)' newest research report, the “Carbohydrate Antigen 19-9 Industry Forecast” looks at past sales and reviews total world Carbohydrate Antigen 19-9 sales in 2022, providing a comprehensive analysis by region and market sector of projected Carbohydrate Antigen 19-9 sales for 2023 through 2029. With Carbohydrate Antigen 19-9 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carbohydrate Antigen 19-9 industry.
This Insight Report provides a comprehensive analysis of the global Carbohydrate Antigen 19-9 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Carbohydrate Antigen 19-9 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Carbohydrate Antigen 19-9 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carbohydrate Antigen 19-9 and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carbohydrate Antigen 19-9.
The global Carbohydrate Antigen 19-9 market size is projected to grow from US$ 92 million in 2022 to US$ 144.2 million in 2029; it is expected to grow at a CAGR of 144.2 from 2023 to 2029.
Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.
This report presents a comprehensive overview, market shares, and growth opportunities of Carbohydrate Antigen 19-9 market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
ELISA
CLIA
Segmentation by application
Pancreatic Cancer
Colon Cancer
Stomach Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Roche
Ortho Clinical Diagnostics
BioMérieux
Fujirebio
KAINOS Laboratories
DiaSorin
Danaher Corporation
Siemens
Tellgen
DIACHA Diagnostics
Sichuan Maccura Biotechnology
Dirui
Chemclin IVD

Key Questions Addressed in this Report
What is the 10-year outlook for the global Carbohydrate Antigen 19-9 market?
What factors are driving Carbohydrate Antigen 19-9 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Carbohydrate Antigen 19-9 market opportunities vary by end market size?
How does Carbohydrate Antigen 19-9 break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.